FindTrial
Sign In

The demonstration study of dominant diseases in the construction and demonstration of dynamic and static TCM clinical evaluation methodology based on the principle of syndrome element identification and state measurability : the study of TCM syndrome element characteristics of chronic kidney disease stage 5D ( Guange ) and the optimal example of individualized diagnosis and treatment of non-drug therapy ( moxibustion ) of ' Fatong disease syndrom

The demonstration study of dominant diseases in the construction and demonstration of dynamic and static TCM clinical evaluation methodology based on the principle of syndrome element identification and state measurability : the study of TCM syndrome element characteristics of chronic kidney disease stage 5D ( Guange ) and the optimal example of individualized diagnosis and treatment of non-drug therapy ( moxibustion ) of ' Fatong disease syndrom

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000808
Enrollment
Unknown
Registered
2024-12-12
Start date
2025-01-01
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease stage 5D

Interventions

Western medicine group:conventional treatment of western medicine
tcm group:Conventional western medicine treatment + traditional Chinese medicine dialectical moxibustion

Sponsors

Wangjing Hospital of CACMS
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: ( 1 ) aged 18-80 years old ; ( 2 ) In line with the Western diagnostic criteria for end-stage renal disease ; ( 3 ) Conform to the diagnostic criteria of TCM syndromes of spleen and kidney yang deficiency syndrome spleen and kidney qi deficiency syndrome yin and yang deficiency syndrome qi and yin deficiency syndrome ; ( 4 ) Regular hemodialysis = 3 months ; ( 5 ) clear consciousness no history of mental illness or personality disorder ; ( 6 ) Actively cooperate with the questionnaire survey and have good compliance with Chinese and Western medicine treatment orders ; ( 7 ) Volunteered to participate in the trial and signed the ' informed consent '.

Exclusion criteria

Exclusion criteria: (1) Life expectancy of less than one year; (2) Patients with severe cardiovascular and cerebrovascular diseases severe primary diseases acute infections malignant tumors severe gastrointestinal and liver diseases and fractures; (3) Poor adherence to medical instructions of Chinese and western medicine; (4) People who are allergic to Moxa tobacco and have a history of skin allergy; (5) Patients with local skin damage or infection and temperature sensory impairment; (6) Surgery within 3 months; (7) Pregnant or lactating women; (8) Mental illness psychological disorders etc. can not cooperate with investigators; (9) Participating in other clinical investigators within or near 1 month; (10) Solid heat syndrome Yin deficiency syndrome.

Design outcomes

Primary

MeasureTime frame
evaluation of quality of life;—

Secondary

MeasureTime frame
Adverse events related to moxibustion therapy;TCM symptom grading quantitative score;Health status evaluation of traditional Chinese medicine;—

Countries

China

Contacts

Public ContactQiu Moyan

Wangjing Hospital of CACMS

2958205507@qq.com010-84739181

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026